Kathy Nicholls
7PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 10, 2026
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension.Peter Nordbeck, Ozlem Goker-Alpan, John A Bernat
|Jun 21, 2024
Enzyme replacement therapy in Fabry cardiomyopathy: an incomplete treatment.Kathleen Nicholls
|Jun 11, 2024
Genomic Testing in Patients with Kidney Failure of an Unknown Cause: A National Australian Study.Amali C Mallawaarachchi, Lindsay Fowles, Louise Wardrop
|May 24, 2024
The Effect of Fabry Disease Therapy on Bone Mineral Density.Tess Aitken, Mark K Tiong, Andrew S Talbot
|Jan 12, 2024
Fabry-specific treatment in Australia: time to align eligibility criteria with international best practices.Kathleen Nicholls, Charles Denaro, Michel Tchan
|Aug 26, 2022
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease.Markus Cybulla, Kathleen Nicholls, Sandro Feriozzi
Pageof 2
Frequent Collaborators
3 joint publications
Michael L West
2 joint publications
Michel Tchan
2 joint publications
Mark Thomas
1 joint publications
Tess Aitken
1 joint publications
Mark K Tiong
1 joint publications
Markus Cybulla
1 joint publications
Sandro Feriozzi
1 joint publications
Joan Torras
1 joint publications
Bojan Vujkovac
1 joint publications
Charles Denaro
